Inventor
HASLETT PATRICK ANTHONY JOHN
US3 patents
Patents
3 patentsUS11059906B2Jul 13, 2021
Anti-CCL2 and anti-LOXL2 combination therapy for treatment of scleroderma
SHIRE HUMAN GENETIC THERAPIES0 citations55
US10639356B2May 5, 2020
Treatment of cognitive impairment of mucopolysaccharidosis type IIIA by intrathecal delivery of heparan N-sulfatase
SHIRE HUMAN GENETIC THERAPIES0 citations39
US10578624B2Mar 3, 2020
Determination of glycosaminoglycan levels by mass spectrometry
SHIRE HUMAN GENETIC THERAPIES0 citations33